Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non-small cell lung cancer

Oncology Reports

Volumn 18, Issue 1, 2007, Pages 81-85

  Hsu, Nan Yung ^a   Chen, Chih Yi ^a   Hsu, Chung Ping ^b   Lin, Tze Yi ^c   Chou, Ming Chih ^d   Chiou, Shiow Her ^e   Chow, Kuan Chih ^e  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c Hsin Chu General Hospital   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Antimetastatic; Cell migration; Non small cell lung cancer; Prognosis

Indexed keywords

FOCAL ADHESION KINASE 1; MESSENGER RNA; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE A; PTK2 PROTEIN, HUMAN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; ENZYME IMMUNOASSAY; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOCAL ADHESION KINASE 1; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEOSIDE-DIPHOSPHATE KINASE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 34548009376     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.1.81     Document Type: Article

References (34)

1. Parkin DM: Epidemiology of cancer: global patterns and trends. Toxicol Lett 102-103: 227-234, 1998.
2. Kubik A, Plesko I and Reissigova J: Prediction of lung cancer mortality in four Central European countries, 1990-2009. Neoplasma 45: 60-67, 1998.
3. Annual reports of the Department of Health, the Executive Yuan, P.R. China, 2003.
4. Melamed MR, Flehinger BJ and Zaman MB: Impact of early detection on the clinical course of lung cancer. Surg Clin North Am 67: 909-924, 1987. (Pubitemid 17158572)
5. Pairolero PC, Williams DE, Bergstralh EJ, et al: Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 38: 331-336, 1984.
6. Hsu NY, Ho HC, Chow KC, et al: Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res 61: 2727-2731, 2001.
7. Deng HB, Parekh HK, Chow KC, et al: Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells. J Biol Chem 277: 15035-15043, 2002. (Pubitemid 34952580)
8. Bhattacharjee A, Richards WG, Staunton J, et al: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98: 13790-13795, 2001. (Pubitemid 33115977)
9. Garber ME, Troyanskaya OG, Schluens K, et al: Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 98: 13784-13789, 2001. (Pubitemid 33115976)
10. Miura K, Bowman ED, Simon R, et al: Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. Cancer Res 62: 3244-3250, 2002. (Pubitemid 34602420)
11. McDoniels-Silvers AL, Nimri CF, Stoner GD, et al: Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 8: 1127-1138, 2002. (Pubitemid 35177366)
12. Nakahara S, Miyoshi E, Noda K, et al: Involvement of oligosaccharide changes in alpha5beta1 integrin in a cisplatinresistant human squamous cell carcinoma cell line. Mol Cancer Ther 2: 1207-1214, 2003.
13. Volm M, Mattern J and Koomagi R: Association between nm23-H1 expression, proliferation and apoptosis in non-small cell lung carcinomas. Clin Exp Metastasis 16: 595-602, 1998. (Pubitemid 29044582)
14. Iizuka N, Hirose K, Noma T, et al: The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma. Br J Cancer 81: 469-475, 1998. (Pubitemid 29458801)
15. Steeg PS, Bevilacqua G, Kopper L, et al: Evidence for a novel gene associated with low tumour metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
16. Scambia G, Ferrandina G, Marone M, et al: Nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters. J Clin Oncol 14: 334-342, 1996. (Pubitemid 26053263)
17. Katakura H, Tanaka F, Oyanagi H, et al: Clinical significance of nm23 expression in resected pathologic-stage I, non-small cell lung cancer. Ann Thorac Surg 73: 1060-1064, 2002. (Pubitemid 34275878)
18. Tomita M, Ayabe T, Matsuzaki Y, et al: Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival. BMC Cancer 1: 3-8, 2001.
19. Pavelic K, Kapitanovic S, Radosevic S, et al: Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis. J Mol Med 78: 111-118, 2000. (Pubitemid 30201934)
20. Wang LS, Chow KC, Lien YC, et al: Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma. Eur J Cardiothorac Surg 26: 419-424, 2004.
21. Wang YF, Chow KC, Chang SY, et al: Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma. Br J Cancer 90: 2186-2193, 2004.
22. Ferguson AW, Flatow U, MacDonald NJ, et al: Increased sensitivity to cisplatin by nm23-transfected tumor cell lines. Cancer Res 56: 2931-2935, 1996. (Pubitemid 26199734)
23. Satoh TH, Surmacz TA, Nyormoi O, et al: Inhibition of focal adhesion kinase by antisense oligonucleotides enhances the sensitivity of breast cancer cells to camptothecins. Biocell 27: 47-55, 2003. (Pubitemid 36781652)
24. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 111: 1710-1717, 1997.
25. Kaplan EL and Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
26. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966.
27. Wagner PD and Vu ND: Phosphorylation of geranyl and farnesyl pyrophosphates by Nm23 proteins/nucleoside diphosphate kinases. J Biol Chem 275: 35570-35576, 2000.
28. Hartsough MT, Morrison DK, Salerno M, et al: Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem 277: 32389-32399, 2002. (Pubitemid 34969057)
29. Krishnan KS, Rikhy R, Rao S, et al: Nucleoside diphosphate kinase, a source of GTP, is required for dynamin-dependent synaptic vesicle recycling. Neuron 30: 197-210, 2001. (Pubitemid 32441687)
30. Caligo MA, Cipollini G, Berti A, et al: NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumour progression. Int J Cancer 74: 102-111, 1997. (Pubitemid 27157864)
31. Hsu NY, Chow KC, Chen WJ, et al: Expression of nm23 in the primary tumor and the metastatic regional lymph nodes of patients with gastric cardiac cancer. Clin Cancer Res 5: 1752-1757, 1999.
32. Chen XF, Zhang HT, Qi QY, et al: Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China. Lung Cancer 48: 69-76, 2005.
33. Gautam A, Li ZR and Bepler G: RRM1-induced metastasis suppression through PTEN-regulated pathways. Oncogene 10: 2135-2142, 2003. (Pubitemid 36539563)
34. Masumoto N, Nakano S, Fujishima H, et al: v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells. Int J Cancer 80: 731-737, 1999. (Pubitemid 29066286)